110 related articles for article (PubMed ID: 1313529)
1. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis.
Lazzarotto T; Paya CV; Smith TF; Wiesner RH; Krom R; Landini MP
Microbiologica; 1992 Jan; 15(1):15-22. PubMed ID: 1313529
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
3. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
4. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
5. Antigenic variation of cytomegalovirus isolates recovered from infected children.
Lazzarotto T; Boccuni MC; Dal Monte P; Ripalti A; Landini MP
Microbiologica; 1991 Jul; 14(3):241-51. PubMed ID: 1656167
[TBL] [Abstract][Full Text] [Related]
6. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
7. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the occurrence of antibodies to human cytomegalovirus as demonstrated by complement fixation, enzyme-linked-immunosorbent assay and indirect immunofluorescence.
Landini MP; Re MC; Coppolecchia P
Boll Ist Sieroter Milan; 1982; 61(4):320-3. PubMed ID: 6100235
[TBL] [Abstract][Full Text] [Related]
9. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
[TBL] [Abstract][Full Text] [Related]
10. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
[TBL] [Abstract][Full Text] [Related]
12. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
13. Detection of antibodies to cytomegalovirus by immunofluorescence and enzyme immunoassay.
Korcáková L; Kaslík J; Slízová I
Czech Med; 1990; 13(1):29-33. PubMed ID: 2161726
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antibody titres against human cytomegalovirus detected by enzyme immunoassay and titres to individual viral polypeptides studied by immunoblotting.
Mirolo G; Landini MP; Baldassarri B; Re MC; Lazzarotto T; La Placa M
Microbiologica; 1986 Jul; 9(3):373-9. PubMed ID: 3018455
[TBL] [Abstract][Full Text] [Related]
15. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
[TBL] [Abstract][Full Text] [Related]
16. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
Basson J; Tardy JC; Aymard M
J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the shell vial pre-CPE method using monoclonal antibodies for the diagnosis of human cytomegalovirus infection in the field of pediatrics.
Numazaki K; Nagata N; Chiba S
In Vivo; 1992; 6(5):513-5. PubMed ID: 1333832
[TBL] [Abstract][Full Text] [Related]
18. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
Landini MP; Rossier E; Schmitz H
J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
